Inventor · disambiguated record
Mark E. Gustafson
Also filed as: GUSTAFSON MARK E
6 granted patents·2 pending applications·122 citations·filing 1992–2007
84Inventor score
Top patents by PatentIndex Score
8 records- 0182US5212091AMethod of producing tissue factor pathway inhibitorMONSANTO CO·Filed 1992·Granted May 18, 1993·71 cites·6 claims
- 0277US6323326B1Method of solubilizing, purifying, and refolding proteinCHIRON CORP·Filed 1996·Granted Nov 27, 2001·31 cites·69 claims
- 0375US7226757B2Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorNOVARTIS VACCINES & DIAGNOSTIC·Filed 2006·Granted Jun 5, 2007·1 cites·31 claims
- 0465US7851433B2Method of purifying TFPI and TFPI analogsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Dec 14, 2010·3 cites·62 claims
- 0565US6319896B1Method of solubilizing, purifying, and refolding proteinCHIRON CORP·Filed 1999·Granted Nov 20, 2001·15 cites·24 claims
- 0661US7022672B2Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorSEARLE LLC·Filed 2001·Granted Apr 4, 2006·1 cites·85 claims
- 0759US2008281084A1Formulation, Solubilization, Purification, and Refolding of Tissue Factor Pathway InhibitorNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Application pending·0 cites
- 0849US2005048056A1Method for the preparation of molecules having antibody activityPHARMACIA CORP·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark E. Gustafson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →